Back to all studies
CompletedNCT06023459

Controlled study of Extended-released Buprenorphine vs. Sublingual Buprenorphine-naloxone in Rural Settings

This study is completed in the United States. It is testing Injectable extended-release buprenorphine for Opioid-Related Disorders; Substance-Related Disorders; Narcotic-Related Disorders.

Addiction, Opioid-Related Disorders, ...BehavioralOver 18 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Injectable extended-release buprenorphine may be useful for adults experiencing addiction.

What would participation involve?

Participants may receive Injectable extended-release buprenorphine, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with addiction.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: October 14, 2024
Recruitment status
Completed
Enrollment listed in the registry
140
Sponsor
Yih-Ing Hser
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT06023459
Official title
Randomized Controlled Pilot Trial of Extended-released Buprenorphine vs. Sublingual Buprenorphine-naloxone in Rural Settings

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT06023459. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 7 sites
  • AppleGate Recovery El Dorado
    El Dorado, Arkansas
    Site status: Not listed — confirm with the team
  • Southern Humboldt Community Healthcare District - Jerold Phelps Community Hospital
    Garberville, California
    Site status: Not listed — confirm with the team
  • Gibson Area Hospital and Health Services - Gibson Recovery Optimizing Wellness
    Gibson City, Illinois
    Site status: Not listed — confirm with the team
  • Penobscot Community Health Care Inc. - Seaport Community Health Center
    Belfast, Maine
    Site status: Not listed — confirm with the team
  • Oregon Health & Science University Primary Care Clinic, Scappoose
    Scappoose, Oregon
    Site status: Not listed — confirm with the team
  • Providence Northeast Washington Medical Group
    Colville, Washington
    Site status: Not listed — confirm with the team
  • New Beginnings Recovery Clinic & Behavioral Health Center
    New Martinsville, West Virginia
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring psychotherapy or therapy for people with addiction. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

What is a behavioral study?

This appears to be a behavioral / psychological / psychosocial study involving Injectable extended-release buprenorphine, Sublingual buprenorphine-naloxone. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Are there criteria about substance use or wanting to reduce it?

The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.

What would I likely need to do?

You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

Could this study affect my mood, habits, motivation, or stress?

Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Yih-Ing Hser, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me